Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project

Hypertension

Volumn 59, Issue 4, 2012, Pages 802-810

  Stocks, Tanja ^a,c   Van Hemelrijck, Mieke ^d   Manjer, Jonas ^e   Bjørge, Tone ^f,g   Ulmer, Hanno ^h   Hallmans, Göran ^b   Lindkvist, Björn ⁱ   Selmer, Randi ^g   Nagel, Gabriele ^j,k   Tretli, Steinar ^l   Concin, Hans ^k   Engeland, Anders ^f,g   Jonsson, Håkan ^a   Stattin, Pär ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Nutritional Research   (Sweden)

^c The Capital Region   (Denmark)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF BERGEN   (Norway)

^g NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j UNIVERSITY OF ULM   (Germany)

^k AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^l CANCER REGISTRY OF NORWAY   (Norway)

more..

Author keywords

blood pressure; Cohort of Norway; cohort studies; neoplasms; prospective studies

Indexed keywords

ADULT; ARTICLE; AUSTRIA; BLADDER CANCER; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; COLON CANCER; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; HUMAN; HYPERTENSION; KIDNEY CANCER; LARYNX CANCER; LIP CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; METABOLIC SYNDROME X; MOUTH CANCER; NORWAY; OBSERVATIONAL STUDY; OROPHARYNX CANCER; PANCREAS CANCER; PRIORITY JOURNAL; RECTUM CANCER; SEX RATIO; SKIN CANCER; SMOKING; SWEDEN; SYSTOLIC BLOOD PRESSURE; UTERINE CERVIX CANCER; UTERUS CANCER;

ADULT; AUSTRIA; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; NORWAY; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SURVIVAL RATE; SWEDEN;

EID: 84858698428     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.189258     Document Type: Article

References (37)

1. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992. (Pubitemid 38296854)
2. Campisi J, Yaswen P. Aging and cancer cell biology, 2009. Aging Cell. 2009;8:221-225.
3. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006;169:1505-1522. (Pubitemid 351181984)
4. Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD. Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol. 2008;26:4672-4678.
5. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, Kaaks R, Stattin P. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond). 2008;32: 304-314. (Pubitemid 351271779)
6. van Heeckeren WJ, Ortiz J, Cooney MM, Remick SC. Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker? J Clin Oncol. 2007;25:2993-2995. (Pubitemid 47218042)
7. Vatten LJ, Trichopoulos D, Holmen J, Nilsen TI. Blood pressure and renal cancer risk: the HUNT Study in Norway. Br J Cancer. 2007;97: 112-114. (Pubitemid 47012085)
8. Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control. 2009;20:1181-1192.
9. Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med. 2002;112: 479-486. (Pubitemid 34450709)
10. Goon PK, Stonelake PS, Lip GY. Hypertension, anti-hypertensive therapy and neoplasia. Curr Pharm Des. 2007;13:2539-2544. (Pubitemid 47423667)
11. Batty GD, Shipley MJ, Marmot MG, Davey Smith G. Blood pressure and site-specific cancer mortality: evidence from the original Whitehall Study. Br J Cancer. 2003;89:1243-1247. (Pubitemid 37363411)
12. Emberson JR, Whincup PH, Morris RW, Walker M, Lowe GD, Rumley A. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil. 2004;11:125-134. (Pubitemid 38591083)
13. Whitlock G, Clark T, Vander Hoorn S, Rodgers A, Jackson R, Norton R, Macmahon S. Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol. 2001;17:907-909. (Pubitemid 34832358)
14. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150: 341-353. (Pubitemid 29383482)
15. Wood AM, White I, Thompson SG, Lewington S, Danesh J. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol. 2006;35:1570-1578.
16. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H, Selmer R, Hallmans G, Concin H, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic Syndrome and Cancer Project (Me-Can): analysis of six prospective cohorts. PLoS Med. 2009;6:e1000201.
17. Stocks T, Borena W, Strohmaier S, Bjorge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P. Cohort profile: the Metabolic Syndrome and Cancer Project (Me-Can). Int J Epidemiol. 2010;39:660-667.
18. Eurostat. European shortlist for causes of death, 1998. http://ec.europa.eu/eurostat/ramon/index.cfm?TargetUrl-DSP-PUB-WELC. Accessed December 1, 2008.
19. Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer. 1967;2:269-279.
20. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
21. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886. (Pubitemid 20026073)
22. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006;49:945-952.
23. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27-33.
24. Cancer Registry of Norway. Cancer in Norway 2006. http://www. kreftregisteret.no/no/Generelt/Publikasjoner/Cancer-in-Norway/ Cancer-in-Norway-2006/. Accessed December 1, 2008.
25. Lindholm LH, Carlberg B. Blood-pressure drugs and cancer: much ado about nothing? Lancet Oncol. 2011;12:6-8.
26. Andreotti G, Boffetta P, Rosenberg PS, Berndt SI, Karami S, Menashe I, Yeager M, Chanock SJ, Zaridze D, Matteev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Rothman N, Brennan P, Chow WH, Moore LE. Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis. 2010;31:614-620.
27. Corrao G, Scotti L, Bagnardi V, Sega R. Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis. Curr Drug Saf. 2007;2: 125-133. (Pubitemid 46805544)
28. Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens. 2005;19:373-379. (Pubitemid 40662858)
29. Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev. 2009; 18:1448-1456.
30. Reis N, Beji NK. Risk factors for endometrial cancer in Turkish women: results from a hospital-based case-control study. Eur J Oncol Nurs. 2009;13:122-127.
31. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:836-842.
32. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens. 2006;20:727-732. (Pubitemid 44430670)
33. Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA. Features of the metabolic syndrome and prostate cancer in African-American men. Cancer. 2007;109:875-881. (Pubitemid 46333529)
34. Lindgren A, Pukkala E, Tuomilehto J, Nissinen A. Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer. 2007; 121:641-644. (Pubitemid 46986498)
35. Lindgren A, Pukkala E, Nissinen A, Tuomilehto J. Blood pressure, smoking, and the incidence of lung cancer in hypertensive men in North Karelia, Finland. Am J Epidemiol. 2003;158:442-447. (Pubitemid 37022842)
36. Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol. 2000;29:495-502. (Pubitemid 30447254)
37. Johansson LA, Westerling R. Comparing hospital discharge records with death certificates: can the differences be explained? J Epidemiol Community Health. 2002;56:301-308. (Pubitemid 34261205)